Patents

US RE47885 E1: Use of cannabidiol prodrugs in pharmaceutical compositions

Granted
2020-03-03
Filed
2018-12-13 application 16219285
Type
Reissue · 8 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Described herein are cannabidiol prodrugs used in pharmaceutical compositions as well as microneedle drug delivery systems comprising a pharmaceutical compositions comprising pharmaceutically active agents (e.g., cannabidiol and prodrugs of cannabidiol) and microneedle arrays suitable for local and systemic delivery of the active agent to a mammal. Also described herein are methods of using a microneedle transdermal or topical drug delivery systems comprising pharmaceutical compositions, comprising cannabidiol and prodrugs of cannabidiol, and microneedle arrays in the treatment disease, including pancreatitis and pancreatic cancer.

Source: PVGPATDIS, file of 2026-04-10 (ipg200303.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
ZYNERBA PHARMACEUTICALS, INC. 13 patentsUS company or organizationDevon, PAZYNERBA PHARMACEUTICALS, INC. Federal lobbying client EXACT high confidence: identical full name and state
ZYNERBA PHARMACEUTICALS, INC. SEC filer EXACT medium confidence: identical full name, one of each nationally
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Audra Lynn StrinchcombTowson, MD1PVGPATDIS, file of 2026-04-10
Stan Lee BanksOwenton, KY6PVGPATDIS, file of 2026-04-10
Miroslaw Jerzy GolinskiVillage of La Jolla, CA12PVGPATDIS, file of 2026-04-10
Jeffrey Lynn HowardRichmond, KY6PVGPATDIS, file of 2026-04-10
Dana Carmel HammelGeorgetown, KY1PVGPATDIS, file of 2026-04-10

CPC categories

No CPC categories reported.

Assignments and security interests

RecordedWhatFromToReel/frameSource
2026-05-18Correction
Supplemental confirmatory grant of security interest in united states patents
HARMONY BIOSCIENCES MANAGEMENT, INC. (F/K/A ZYNERBA PHARMACEUTICALS, INC.) signed 2026-05-04JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT CHICAGO, IL75642/639PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.